GGrantIndex
← Search

Core--Magnetic resonance imaging and spectroscopy

$0P30FY2002CANIH

University Of Chicago, Chicago IL

Investigators

Linked publications, trials & patents

Paper 39661064Paper 39579248Paper 39438113Paper 39374047Paper 39270007Paper 39141403Paper 39114540Paper 39108474Paper 39071306Paper 39069988Paper 38883758Paper 38881356Paper 38849889Paper 38810242Paper 38771643Paper 38752924Paper 38735044Paper 38716867Paper 38691450Paper 38632339Paper 38561491Paper 38548994Paper 38536082Paper 38533736Paper 38496521Paper 38427437Paper 38421866Paper 38381713Paper 38294692Paper 38294689Paper 38293065Paper 38219706Paper 38213818Paper 38190286Paper 38186960Paper 38175791Paper 38155245Trial NCT02573363Trial NCT02573220Trial NCT02542202Trial NCT02540876Trial NCT02485535Trial NCT02420210Trial NCT02399371Trial NCT02389517Trial NCT02366819Trial NCT02333188Trial NCT02333162Trial NCT02275533Trial NCT02258659Trial NCT02213913Trial NCT02199665Trial NCT02122172Trial NCT02046421Trial NCT02012296Trial NCT01949740Trial NCT01861301Trial NCT01696955Trial NCT01576172Trial NCT01307618Trial NCT01281176Trial NCT01278615Trial NCT01267266Trial NCT01256385Trial NCT01208051Trial NCT01174264Trial NCT01122888Trial NCT01076543Trial NCT01064622Trial NCT00859937Trial NCT00720174Trial NCT00504153Trial NCT00436579Trial NCT00387335Trial NCT00381641Trial NCT00376688Trial NCT00369551Trial NCT00351975Trial NCT00303862Trial NCT00290472Trial NCT00265798Trial NCT00126542Trial NCT00095784Trial NCT00091026Trial NCT00087373Trial NCT00062075Trial NCT00058019Trial NCT00055913Trial NCT00039416Trial NCT00027703Trial NCT00023946Patent 7192711Patent 6870037Patent 6482934Patent 6387619Patent 6043216Patent 5916752Patent 5786344Patent 5698686Patent 5618917

Abstract

DESCRIPTION (provided by applicant): Magnetic Resonance imaging technology has important applications to cancer treatment. It provides excellent soft tissue contrast, high spatial resolution, and a wide range of functional information. It is completely non-invasive and poses no significant risks to patients. Thus the faculty of the UCCRC have devoted significant effort towards development and application of MRI methods. The Magnetic Resonance Imaging and Spectroscopy Core is a new addition to the University of Chicago Cancer Center which will expand the availability of our MR resources to Cancer Center investigators. The mission of the MRIS core is to promote the development and application of MR technology for 1) early detection of cancer, 2) evaluation of new therapeutic agents 3) and image guided design of therapies. The MRIS laboratory emphasizes translational research. New methods for detecting cancer and evaluating response to therapy are developed and applied in animal models using a 4.7 Tesla 30 cm bore research MR scanner. Subsequently some of these new methods are evaluated on clinical scanners. In addition, the MRIS laboratory uses conventional MRI imaging to support clinical research such as evaluation of new drugs. Specifically the MRIS Core will provide the following support for studies of animal models of cancer and cancer patients; 3-dimensional volumetric high resolution images that depict the anatomy and size of tumors and changes during therapy; Measurement of hemodynamic parameters, i.e., tumor blood flow, blood volume, capillary permeability, and vascular architecture, and changes in these parameters during therapy; Measurements of tumor oxygenation. Changes in oxygenation caused by tumor oxygenating agents; Measurements of metabolites involved with high energy phosphate metabolism, glycolysis, and lipid metabolism; Other important functional measurements such as water diffusion rates and pH; Development and testing of new MR methods that are likely to increase the sensitivity and specificity of MR scans; Development and testing of new contrast agents; High resolution MRI of tissue samples; and Teaching: The MRIS Core facility is a focal point for instruction of Radiologists and Medical physicists in basic MR technology and its application to cancer treatment. Instruction includes lectures and hands on laboratory experience. The primary focus of the MRIS core will be to support pilot projects that are evaluated and approved by a steering committee. These pilot studies will produce preliminary results in support of applications for external funding that will make these projects self-sufficient. The MRIS Core will foster strong collaborations between oncologists, radiologists, and imaging scientists. Because studies of animal models of disease and clinical studies will be supported, this program will be an important source of translational research.

View original record on NIH RePORTER →